SCHEMBL14847360

SCHEMBL14847360

COc1cc(-c2nnn(C)c2-c2ccc(-c3nnnn3C)cc2)cc2c1OCO2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.42
KMT2A Q03164 3/20 0.42
MAPT P10636 3/20 0.42
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 2/20 0.42
HPGD P15428 2/20 0.42
LMNA P02545 1/20 0.42
HTT P42858 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
NPSR1 Q6W5P4 1/20 0.39
TP53 P04637 2/20 0.37
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
CYP3A4 P08684 2/20 0.36
LRRK2 Q5S007 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
CTSL P07711 1/20 0.34
CTSB P07858 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL410895 0.83 ALDH1A1 (0.46) ALDH1A1KMT2AMAPTKDM4EMEN1
SCHEMBL1168211 0.83 ALDH1A1 (0.40) ALDH1A1KMT2AMAPTKDM4EMEN1
SCHEMBL618379 0.82 ALDH1A1 (0.40) ALDH1A1KMT2AMAPTKDM4EMEN1
SCHEMBL6525954 0.80 NPC1 (0.39) ALDH1A1KMT2AMAPTKDM4EMEN1
SCHEMBL1169106 0.79 KMT2A (0.39) ALDH1A1KMT2AMAPTKDM4EMEN1
SCHEMBL617582 0.79 PTGS2 (0.40) ALDH1A1KMT2AMAPTKDM4EMEN1
SCHEMBL10189635 0.75 ALDH1A1 (0.40) ALDH1A1KMT2AMAPTKDM4EMEN1
SCHEMBL14619167 0.74 MAPT (0.51) ALDH1A1KMT2AMAPTKDM4EMEN1
SCHEMBL10189784 0.70 ALDH1A1 (0.33) ALDH1A1KMT2AMAPTKDM4EMEN1
SCHEMBL31237366 0.67 ALDH1A1 (0.60) ALDH1A1KMT2AMAPTKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919881-B1 1, 2, 3 -TRIAZOLES INHIBITORS OF TUBULIN POLYMERIZATION FOR THE TREATMENT OF POLIFERATIVE DISORDERS SYNTA PHARMACEUTICALS CORP (US) 2013-04-10 EP disclosed